Inicio>>Signaling Pathways>> Tyrosine Kinase>> FGFR>>FIIN 1 hydrochloride

FIIN 1 hydrochloride (Synonyms: FGFR irreversible inhibitor-1)

Catalog No.GC50051

El clorhidrato de FIIN 1 es un inhibidor de FGFR selectivo, irreversible y potente. El clorhidrato de FIIN 1 se une a FGFR1/2/3/4 y Flt1/4 con Kds de 2,8/6,9/5,4/120 nM y 32/120 nM respectivamente. Las CI50 bioquÍmicas del clorhidrato de FIIN 1 son 9,2, 6,2, 11,9 y 189 nM frente a FGFR1/2/3/4, respectivamente.

Products are for research use only. Not for human use. We do not sell to patients.

FIIN 1 hydrochloride Chemical Structure

Cas No.: 1256152-35-8

Tamaño Precio Disponibilidad Cantidad
2mg
203,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Potent, irreversible FGFR inhibitor (Kd values are 2.8, 5.4, 6.9 and 120 nM for FGFR1, FGFR3, FGFR2 and FGFR4 respectively); acts at the ATP binding site. Also irreversibly inhibits Flt-1, Flt-4 and VEGFR-2 (Kd values are 32, 120 and 210 nM respectively); displays limited activity (Kd >500 nM) at other kinases. Exhibits antiproliferative activity in FGFR3- and FGFR1-transformed Ba/F3 cells (EC50 values are 10 and 14 nM respectively). Derived from the reversible FGFR inhibitor, PD 173074.

Zhou (2010) A structure-guided approach to creating covalent FGFR inhibitors. Chem.Biol. 17 285 PMID:20338520

Reseñas

Review for FIIN 1 hydrochloride

Average Rating: 5 ★★★★★ (Based on Reviews and 33 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for FIIN 1 hydrochloride

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.